Hyuons Ceftriaxone Sodium Injection 1g

Adult administration

Adults and children over 12 years: Administer 1-2g (potency) of ceftriaxone intravenously or intramuscularly once daily. For severe infections or infections caused by moderately susceptible pathogens, the dose may be increased to 4g (potency) once daily. Elderly: Follow the adult dosage and administration without changes. For gonorrhea treatment: A single intramuscular injection of 250mg (potency) is recommended. Prevention of pre- and post-operative infections

Child administration

Neonates (within 14 days of birth): Administer 20-50mg (potency) per kg of body weight once daily, not to exceed 50mg (potency) per kg. Administered regardless of premature or full-term status. Infants and young children

This medication may form precipitate if used with calcium-containing solutions; therefore, it should not be mixed or administered simultaneously with fluids or medications containing calcium. It is particularly contraindicated for neonates due to the increased risk of precipitation with calcium. Patients with allergic reactions to this medication or hypersensitivity to cephalosporins or penicillin antibiotics should not use it. Administration in neonates with bilirubin binding disorders can pose a risk of bilirubin encephalopathy. Patients with severe renal impairment may require dosage adjustments and careful monitoring due to the potential for increased drug concentration. Regular tests for liver function, kidney function, and blood counts are recommended during treatment, and any unusual symptoms should prompt immediate consultation with healthcare professionals. Rarely, this medication can cause various side effects such as allergic reactions, gastrointestinal disorders, skin rashes, blood abnormalities, and neurological issues, so symptoms should be carefully monitored. Women who are pregnant or breastfeeding should consult with a doctor before using this medication if treatment is necessary, and elderly patients may have an increased risk of side effects due to decreased physical function, requiring careful observation and dosage adjustments. This medication may cause dizziness when driving or operating machinery, so caution is advised. To prevent antibiotic resistance, it should be administered for only the minimum necessary duration, and any unusual symptoms such as diarrhea after administration should be reported immediately to healthcare professionals.

Serious side effects

Hives, severe swelling (edema), swelling, difficulty breathing, anaphylaxis, anaphylactic reactions, sweating, pallor, skin shedding, severe skin reactions, high fever with severe rash, blisters, pain in oral/ocular mucosa, difficulty or trouble breathing, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, lightning

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• headache
• dizziness
• bronchospasm
• loose stools

This medication should be stored in a sealed container away from air and at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and prevent deterioration.

Appearance

A vial containing a white to pale yellow powder

Package unit

1 vial